Q4 2024 |
48 |
$1.82B |
+$261M |
-$240M |
+$20.8M |
MLTX, PRAX, JANX, ACLX, EWTX
|
13F-HR |
2/14/2025, 03:01 PM |
Q3 2024 |
45 |
$1.89B |
+$142M |
-$157M |
-$15.2M |
MLTX, PCVX, ACLX, LBPH, EWTX
|
13F-HR |
11/14/2024, 03:11 PM |
Q2 2024 |
47 |
$1.72B |
+$329M |
-$582M |
-$253M |
MLTX, CRBP, ACLX, PCVX, LBPH
|
13F-HR |
8/14/2024, 03:05 PM |
Q1 2024 |
51 |
$2.04B |
+$551M |
-$504M |
+$47.5M |
MLTX, ACLX, ALPN, BBIO, PRAX
|
13F-HR |
5/15/2024, 03:22 PM |
Q4 2023 |
47 |
$2.09B |
+$534M |
-$602M |
-$68.1M |
MLTX, AMAM, EYPT, BBIO, ACLX
|
13F-HR |
2/14/2024, 03:11 PM |
Q3 2023 |
69 |
$1.7B |
+$290M |
-$277M |
+$12.6M |
MLTX, BBIO, AMAM, ACLX, APLS
|
13F-HR |
11/14/2023, 03:25 PM |
Q2 2023 |
84 |
$1.79B |
+$330M |
-$426M |
-$96.7M |
MLTX, AMAM, APLS, BMEA, BBIO
|
13F-HR |
8/14/2023, 04:19 PM |
Q1 2023 |
72 |
$1.52B |
+$319M |
-$138M |
+$180M |
RXDX, MLTX, BMEA, APLS, AMAM
|
13F-HR |
5/15/2023, 03:34 PM |
Q4 2022 |
73 |
$1.49B |
+$187M |
-$127M |
+$60.4M |
RXDX, APLS, ACLX, MLTX, RNA
|
13F-HR |
2/14/2023, 02:17 PM |
Q3 2022 |
73 |
$1.43B |
+$277M |
-$42.3M |
+$234M |
RXDX, APLS, DSGN, ERAS, ACLX
|
13F-HR |
11/14/2022, 02:23 PM |
Q2 2022 |
79 |
$1.32B |
+$287M |
-$122M |
+$164M |
TPTX, DSGN, ERAS, RXDX, APLS
|
13F-HR |
8/15/2022, 03:08 PM |
Q1 2022 |
76 |
$1.3B |
+$230M |
-$86.9M |
+$143M |
TPTX, ERAS, DSGN, RXDX, GRNA
|
13F-HR |
5/16/2022, 03:07 PM |
Q4 2021 |
78 |
$1.68B |
+$152M |
-$192M |
-$40.9M |
ERAS, TPTX, DSGN, RXDX, FMTX
|
13F-HR |
2/14/2022, 02:19 PM |
Q3 2021 |
88 |
$2.46B |
+$465M |
-$348M |
+$117M |
ERAS, TPTX, AVIR, FMTX, RVMD
|
13F-HR |
11/15/2021, 03:14 PM |
Q2 2021 |
100 |
$2.56B |
+$487M |
-$887M |
-$400M |
TPTX, AVIR, FMTX, BBIO, DSGN
|
13F-HR |
8/16/2021, 03:13 PM |
Q1 2021 |
115 |
$3.47B |
+$728M |
-$419M |
+$309M |
AVIR, TPTX, DSGN, BBIO, FMTX
|
13F-HR |
5/17/2021, 03:46 PM |
Q4 2020 |
105 |
$4.2B |
+$1.4B |
-$238M |
+$1.17B |
TPTX, AVIR, QQQ, XBI, SPY
|
13F-HR |
2/16/2021, 02:21 PM |
Q3 2020 |
93 |
$2.6B |
+$345M |
-$346M |
-$1.12M |
TPTX, SPY, FMTX, RVMD, BBIO
|
13F-HR |
11/16/2020, 03:13 PM |
Q2 2020 |
79 |
$2.6B |
+$495M |
-$481M |
+$13.2M |
TPTX, SPY, FMTX, CCXI, PRNB
|
13F-HR |
8/14/2020, 03:17 PM |
Q1 2020 |
73 |
$2.15B |
+$600M |
-$271M |
+$329M |
SPY, TPTX, PRNB, BBIO, CCXI
|
13F-HR |
5/15/2020, 03:07 PM |
Q4 2019 |
67 |
$2.51B |
+$562M |
-$257M |
+$305M |
TPTX, RETA, MRTX, CCXI, PRNB
|
13F-HR |
2/14/2020, 02:36 PM |
Q3 2019 |
74 |
$1.64B |
+$333M |
-$127M |
+$206M |
TPTX, MRTX, SPY, APLS, RETA
|
13F-HR |
11/14/2019, 02:10 PM |
Q2 2019 |
72 |
$1.74B |
+$540M |
-$184M |
+$356M |
TPTX, MRTX, XBI, RETA, APLS
|
13F-HR |
8/14/2019, 03:17 PM |
Q1 2019 |
64 |
$1.48B |
+$498M |
-$232M |
+$265M |
IFRX, XBI, MRTX, ASND, APLS
|
13F-HR |
5/15/2019, 03:31 PM |
Q4 2018 |
70 |
$1.23B |
+$233M |
-$127M |
+$106M |
TSRO, MRTX, ANAB, TSRO, APLS
|
13F-HR |
2/14/2019, 02:35 PM |
Q3 2018 |
65 |
$1.54B |
+$233M |
-$185M |
+$48M |
ANAB, MRTX, NKTR, NKTR, AVRO
|
13F-HR |
11/14/2018, 02:15 PM |
Q2 2018 |
57 |
$1.35B |
+$307M |
-$59.2M |
+$248M |
APLS, MRTX, NKTR, ANAB, NKTR
|
13F-HR |
8/14/2018, 03:11 PM |
Q1 2018 |
52 |
$1.34B |
+$333M |
-$50.7M |
+$283M |
NKTR, NKTR, ANAB, APLS, MRTX
|
13F-HR |
5/15/2018, 03:54 PM |
Q4 2017 |
52 |
$955M |
+$514M |
-$63.3M |
+$450M |
ANAB, NKTR, APLS, NKTR, OMER
|
13F-HR |
2/14/2018, 02:39 PM |
Q3 2017 |
51 |
$550M |
+$94.4M |
-$119M |
-$25M |
MYOK, RXDX, OMER, ANAB, TBPH
|
13F-HR |
11/14/2017, 02:17 PM |
Q2 2017 |
69 |
$601M |
+$111M |
-$76.9M |
+$34.2M |
PTLA, TBPH, BLUE, QTNT, OMER
|
13F-HR |
8/14/2017, 03:15 PM |
Q1 2017 |
74 |
$676M |
+$57.1M |
-$142M |
-$85.1M |
TBPH, NVRO, PTI, GLPG, ANAB
|
13F-HR |
5/15/2017, 03:23 PM |
Q4 2016 |
76 |
$742M |
+$99.8M |
-$32.9M |
+$67M |
PTI, TBPH, NVRO, ALDR, EGRX
|
13F-HR |
2/14/2017, 02:22 PM |
Q3 2016 |
81 |
$890M |
+$171M |
-$9.66M |
+$162M |
ALDR, NVRO, TBPH, NERVXXXX, PTI
|
13F-HR |
11/14/2016, 01:58 PM |
Q2 2016 |
83 |
$704M |
+$138M |
-$45.6M |
+$92.1M |
ALDR, NVRO, HRTX, TSRO, NKTR
|
13F-HR |
8/15/2016, 04:12 PM |
Q1 2016 |
83 |
$663M |
+$142M |
-$342K |
+$141M |
ALDR, HRTX, SAGE, OMER, NKTR
|
Restatement |
5/17/2016, 04:50 PM |
Q4 2015 |
81 |
$835M |
+$139M |
-$20M |
+$119M |
ALKS, DYAX, HRTX, EGRX, NBIX
|
13F-HR |
2/16/2016, 03:11 PM |
Q3 2015 |
85 |
$619M |
+$80.8M |
-$3.17M |
+$77.6M |
HRTX, ALKS, NBIX, DYAX, ARDX
|
13F-HR |
11/16/2015, 03:08 PM |
Q2 2015 |
80 |
$752M |
+$157M |
-$85.7M |
+$70.8M |
ALKS, HRTX, RCPT, ALDR, DYAX
|
13F-HR |
8/14/2015, 04:22 PM |
Q1 2015 |
71 |
$647M |
+$102M |
-$144M |
-$41.7M |
RCPT, ALKS, PBYI, EGRX, BMY
|
13F-HR |
5/15/2015, 04:18 PM |
Q4 2014 |
69 |
$645M |
+$180M |
-$89.2M |
+$91.2M |
RCPT, PBYI, CELG, OVAS, ALKS
|
13F-HR |
2/17/2015, 03:20 PM |
Q3 2014 |
64 |
$485M |
+$177M |
-$19.2M |
+$158M |
PBYI, RCPT, JAZZ, DYAX, KERX
|
13F-HR |
11/14/2014, 10:21 AM |
Q2 2014 |
52 |
$372M |
+$135M |
-$43.6M |
+$91M |
RCPT, OMER, QCOR, KPTI, DYAX
|
13F-HR |
8/14/2014, 11:21 AM |
Q1 2014 |
46 |
$435M |
+$202M |
-$47.1M |
+$155M |
MDVN, CBST, PBYI, BMRN, RCPT
|
13F-HR |
5/15/2014, 11:20 AM |
Q4 2013 |
37 |
$345M |
|
|
|
MDVN, CBST, KERX, DYAX, PBYI
|
13F-HR |
2/14/2014, 09:50 AM |